- The trend backdrop is active with a 6-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
LLY
MEX
Week ended 07 Aug 2026
Weekly Investor Report
Eli Lilly and Company · Healthcare · Drug Manufacturers - General
Latest close
20,245 MXN
1.7%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 10.4% above the Trend Line and sits at 85.4% of its 52-week range. The latest completed week returned 1.7%, after a -2.2% four-week move. The latest news-sentiment score is 58/100.
Setup score
65
out of 100
Latest Close
20,245 MXN
7 Aug 2026
1W Return
1.7%
latest completed week
4W Return
-2.2%
short-term follow-through
12W Return
15.6%
quarterly tape
Trend Breadth
48.1%
25 of 52 weeks active
Volume Ratio
3.4x
vs 13-week average
- 2 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.7%
Latest completed week; four-week move -2.2%.
Indicator stack
47/70
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
58/100
27 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 10.4% above the Trend Line and sits at 85.4% of its 52-week range. The latest completed week returned 1.7%, after a -2.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 3.4x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7712-week average 0.44
12-week confirmation
Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.77Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -2.2% over four weeks, 15.6% over 12 weeks, and 73.9% over one year. The current trend has remained active for 6 consecutive weeks.
Performance by holding period
Active trend streak6 weeks
Active weeks in one year25
Trend breadth48.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.03Latest activity-pressure read.
Pressure change18.3%Four-week change in activity pressure.
Leadership13.37Latest relative-leadership reading.
RS change-29.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment58/100
Weighted news tone is positive across 27 relevant articles.
15 positive · 8 neutral · 5 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-6.7%Distance below the 52-week high.
13-week volatility4.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+10.4%Week of 26 Jun.
Worst week-8.1%Week of 20 Mar.
Latest week+1.7%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains8
Flat weeks0
Modest losses10
Sharp losses3
Recent vol4.0%13-week weekly-return volatility.
Base vol4.8%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew4.5% / -2.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorMX Healthcare
4-week rank50 / 78
Group average-1.2%
Trend breadth29.5%
Trend29.5%active weekly trend signals
MD62.8%positive activity pressure
RS35.9%positive relative leadership
Four-week leaders
IndustryMX Drug Manufacturers - General
4-week rank9 / 14
Group average1.1%
Trend breadth42.9%
Trend42.9%active weekly trend signals
MD78.6%positive activity pressure
RS64.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape64/100
Trend, activity pressure, participation, and risk combine to a 64/100 tape read.
Indicator analysis69/100Latest 12-week confirmation: trend 6/12, activity pressure 11/12, relative leadership 12/12.
Activity pressure 0.77; 2 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment58/100Weighted news tone is positive across 27 relevant articles.
Berenberg Cuts Novo Nordisk as Lilly Takes the Oral Market Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 20,245 MXN | 1.7% | 18,342 MXN | 15,293 MXN | 1.03 | 13.37 | 10.8K | On |
| 31 Jul 2026 | 19,900 MXN | -4.4% | 18,316 MXN | 15,221 MXN | 1.03 | 12.26 | 436 | On |
| 24 Jul 2026 | 20,821 MXN | 0.4% | 18,291 MXN | 15,143 MXN | 1.12 | 18.81 | 5.9K | On |
| 17 Jul 2026 | 20,736 MXN | 0.1% | 18,238 MXN | 15,058 MXN | 1.08 | 18.32 | 9.6K | On |
| 10 Jul 2026 | 20,708 MXN | -1.5% | 18,190 MXN | 14,975 MXN | 0.87 | 18.87 | 4.8K | On |
| 3 Jul 2026 | 21,029 MXN | -0.5% | 18,108 MXN | 14,891 MXN | 0.77 | 20.14 | 0 | On |
| 26 Jun 2026 | 21,143 MXN | 10.4% | 18,021 MXN | 14,805 MXN | 0.79 | 21.05 | 1.7K | Off |
| 19 Jun 2026 | 19,149 MXN | -2.6% | 17,968 MXN | 14,721 MXN | 0.75 | 9.32 | 0 | Off |
| 12 Jun 2026 | 19,655 MXN | -0.8% | 17,984 MXN | 14,648 MXN | 0.71 | 11.98 | 259 | Off |
| 5 Jun 2026 | 19,812 MXN | 3.4% | 17,957 MXN | 14,571 MXN | 0.47 | 16.16 | 2.9K | Off |
| 29 May 2026 | 19,166 MXN | 3.7% | 17,866 MXN | 14,494 MXN | 0.03 | 8.75 | 3.6K | Off |
| 22 May 2026 | 18,490 MXN | 5.6% | 17,762 MXN | 14,420 MXN | -0.44 | 5.54 | 890 | Off |
| 15 May 2026 | 17,512 MXN | 6.9% | 17,656 MXN | 14,349 MXN | -0.76 | 0.75 | 876 | Off |
| 8 May 2026 | 16,377 MXN | 0.2% | 17,564 MXN | 14,287 MXN | -0.92 | -8.29 | 3.8K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.